about
Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinaseZebrafish lipid metabolism: from mediating early patterning to the metabolism of dietary fat and cholesterol.Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis.The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study.Studying Lipid Metabolism and Transport During Zebrafish Development.Positron emission tomography probe demonstrates a striking concentration of ribose salvage in the liver.Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectivesCurcumin protects hepatic stellate cells against leptin-induced activation in vitro by accumulating intracellular lipids.Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in JapanHepatitis B virus X protein regulates hepatic glucose homeostasis via activation of inducible nitric oxide synthase.Higher-order chromatin regulation and differential gene expression in the human tumor necrosis factor/lymphotoxin locus in hepatocellular carcinoma cellsThe Framingham risk score and heart disease in nonalcoholic fatty liver disease.Decreased skin-mediated detoxification contributes to oxidative stress and insulin resistance.Experimental Nonalcoholic Steatohepatitis Induced by Neonatal Streptozotocin Injection and a High-Fat Diet in Rats.The skin function: a factor of anti-metabolic syndromeWhat is the role of adiponectin in obesity related non-alcoholic fatty liver disease?The β-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosisSirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer.Longitudinal association of obesity, metabolic syndrome and diabetes with risk of elevated aminotransferase levels in a cohort of Mexican health workers.Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) signaling regulates mitochondrial biogenesis and respiration via estrogen-related receptor α (ERRα).Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans.Hepatic fatty acid trafficking: multiple forks in the roadLeptin-cytokine crosstalk in breast cancer.Nicotinamide overload may play a role in the development of type 2 diabetesProtective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications.A new model system swims into focus: using the zebrafish to visualize intestinal metabolism in vivo.Dietary methyl-consuming compounds and metabolic syndrome.AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseasesShedding light on mitochondrial function by real time monitoring of NADH fluorescence: I. Basic methodology and animal studies.Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice.New Discriminant Method for Identifying the Aggressive Disease Phenotype of Non-alcoholic Fatty Liver Disease.High-fat diet causes increased serum insulin and glucose which synergistically lead to renal tubular lipid deposition and extracellular matrix accumulation.Association between Metabolic Syndrome and Lower Urinary Tract Symptoms: Evidences from Epidemiological Studies.Three-dimensional magnetic resonance imaging for stringent diagnosis of advanced fibrosis associated with nonalcoholic steatohepatitis.Nonalcoholic fatty liver disease: from lipid profile to treatment.Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.
P2860
Q28577564-ABAC0EB3-44BB-404B-9BB5-DA06DB383DB8Q30402413-BF40BD27-6127-4AC4-860B-4BF1C1D20B4BQ33397694-D899BB3A-5C32-4801-82DD-7BAB704F06D8Q33514542-BCAC99E7-7FFE-4D0E-97D4-732E765C6B7AQ33564184-6A2B241E-4610-4E3B-8EE1-5CD0E8CE9FA6Q33757419-4082CE03-DABD-4C74-AEFA-E4D34479FADBQ33792421-171CA4E2-2261-44CA-B2ED-82CAA27FE757Q33925802-88F8E1D4-2C01-4F55-82A0-3EB8A2A8058CQ34060084-FFC6825A-4E86-48BD-82C2-E8A933AA990BQ34132375-81336616-650B-469C-8F03-494827A46E52Q34511046-3A84EC7A-842C-4166-A57E-60D60E509E16Q35201779-0DBD9A52-2E7A-4200-860A-AE031070B215Q35289022-55276932-E7CA-48C8-B9E9-60EF46AD1EA4Q35313995-D1452A38-E462-4B90-BF65-8C2D707B9FACQ35867922-A1B8E7F3-F292-4291-AD1B-6D1FD21D0BDDQ35946523-FAA02941-B047-49D3-8A6C-02950AD0D48AQ36152041-1307E8BD-0513-44B0-874C-C164C663F1F9Q36528723-896E1336-7703-48F6-B00A-032A63389ABAQ36595629-A1C6A7D3-933F-45EB-A825-772456B3F6F9Q36616784-9A934BA3-DEE6-456B-92CC-266DA268B6F1Q36784008-E64CEAB1-3272-4473-8979-60D243F449ADQ36809695-307E3347-F2DB-4FE4-8FD9-4755D9E18EE5Q37116105-DDBB679D-8461-4FB7-A931-343C0216213BQ37132025-D3267F83-5A2B-4F5B-B842-48D24DEED354Q37241524-B106C734-AC5B-4A03-A2A9-C217A0C1A735Q37296476-970898E0-F3E8-41DA-A192-DCB4422FCD12Q37351155-EF202F57-55D3-49A5-9061-14F6338B7EFEQ37461169-0B8206AB-7705-42EF-8269-1D422E23BACDQ37494299-7280C9EC-528B-40C1-8F20-CD151B9789D7Q37696293-DF0961E1-DC10-4F72-915C-A74F022BC159Q37911259-BFECFB9C-E3DA-4D09-9335-F556345EDD9FQ38026549-18182BA9-0F2D-43CA-90E3-AF9F62A550C1Q38064338-4D2E2DDB-3668-4EB1-88D6-4F2B6575E547Q38325855-253EE047-3DFB-4D94-B86B-8352AFB5462EQ38720197-8C8D7D02-B875-41ED-8CF8-636A3940B4E6Q39511864-C2C5D07C-5975-402D-AA4B-3F2ECA452A15Q39648996-36FB0639-8A12-4A19-8EDE-481A3A52CFA3Q40706953-CA7DEF84-FDDC-4AF5-92F9-5E34763FA5ABQ40729988-53EEB88D-774B-4CCA-A25E-A2DAA2BE6C44Q40903867-45FCDD1B-0F61-4997-AEFF-50A59155CA42
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Liver diseases and metabolic syndrome.
@en
Liver diseases and metabolic syndrome.
@nl
type
label
Liver diseases and metabolic syndrome.
@en
Liver diseases and metabolic syndrome.
@nl
prefLabel
Liver diseases and metabolic syndrome.
@en
Liver diseases and metabolic syndrome.
@nl
P2093
P2860
P1476
Liver diseases and metabolic syndrome.
@en
P2093
Akihisa Miyazaki
Kenichi Ikejima
Reiko Yaginuma
Sumio Watanabe
P2860
P304
P356
10.1007/S00535-008-2193-6
P577
2008-07-23T00:00:00Z